Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast

Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	Price	Price Target	Upside/Downside	Consensus	Analysts	Fore. Revenue Growth	Fore. Earnings Growth	Forecast ROE	Forecast ROA
MNDR	MOBILE-HEALTH NETWORK SOLUTIONS	N/A	$2.02	N/A	N/A	N/A	N/A	90.29%	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$141.01M	$4.04	$15.20	276.24%	Hold	5	N/A	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$157.00M	$0.69	$8.60	1,139.19%	Strong Buy	5	N/A	N/A	N/A	N/A
IMUX	IMMUNIC INC	$112.15M	$1.25	$10.00	703.21%	Strong Buy	1	N/A	N/A	N/A	N/A
CDXS	CODEXIS INC	$254.71M	$3.61	$9.00	149.31%	Strong Buy	1	2.69%	N/A	N/A	N/A
TLIS	TALIS BIOMEDICAL CORP	$34.24M	$8.98	N/A	N/A	N/A	N/A	N/A	N/A	-218.95%	-150.45%
AWH	ASPIRA WOMEN's HEALTH INC	$33.12M	$2.66	$3.30	24.06%	Hold	1	19.01%	N/A	N/A	N/A
ARAY	ACCURAY INC	$161.77M	$1.63	$9.00	452.15%	Strong Buy	1	3.61%	N/A	N/A	N/A
GBIO	GENERATION BIO CO	$243.50M	$3.66	$7.50	104.92%	Buy	2	-0.99%	N/A	N/A	N/A
IBIO	IBIO INC	$17.07M	$1.98	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MNMD	MIND MEDICINE (MINDMED) INC	$590.79M	$8.22	$26.60	223.60%	Buy	5	N/A	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$10.67M	$0.61	$2.00	227.87%	Strong Buy	2	N/A	N/A	N/A	N/A
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$1.41B	$16.17	$38.60	138.71%	Strong Buy	5	N/A	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$395.51M	$6.44	$13.00	101.86%	Strong Buy	1	N/A	N/A	N/A	N/A
BJDX	BLUEJAY DIAGNOSTICS INC	$1.68M	$0.58	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PRLD	PRELUDE THERAPEUTICS INC	$219.72M	$4.00	$5.33	33.33%	Hold	3	N/A	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$117.08M	$0.65	$4.00	517.28%	Buy	1	N/A	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$291.88M	$9.80	$28.40	189.80%	Strong Buy	5	N/A	N/A	N/A	N/A
ELAB	ELEVAI LABS INC	$12.94M	$0.69	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$83.72M	$1.11	$4.00	260.36%	Buy	2	N/A	N/A	N/A	N/A
GNPX	GENPREX INC	$5.35M	$2.55	$10.00	292.16%	Buy	1	N/A	N/A	N/A	N/A
OMCL	OMNICELL INC	$1.40B	$30.44	$32.00	5.12%	Buy	2	0.09%	N/A	N/A	N/A
INGN	INOGEN INC	$208.19M	$8.83	$7.00	-20.72%	Hold	1	1.93%	N/A	N/A	N/A
XYLO	XYLO TECHNOLOGIES LTD	$3.58M	$1.91	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASRT	ASSERTIO HOLDINGS INC	$101.78M	$1.07	$3.00	180.37%	Strong Buy	1	-14.31%	N/A	N/A	N/A
SXTC	CHINA SXT PHARMACEUTICALS INC	$837.03k	$1.15	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OGEN	ORAGENICS INC	$10.44M	$2.33	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BFRI	BIOFRONTERA INC	$5.45M	$1.07	N/A	N/A	N/A	N/A	25.23%	N/A	N/A	N/A
BBLG	BONE BIOLOGICS CORP	$2.07M	$1.88	N/A	N/A	N/A	N/A	N/A	N/A	-11,212.80%	-10,732.04%
RPHM	RENEO PHARMACEUTICALS INC	$58.49M	$1.75	$1.43	-18.11%	Hold	3	N/A	N/A	N/A	N/A
XRTX	XORTX THERAPEUTICS INC	$7.26M	$2.50	$14.00	460.00%	Strong Buy	1	N/A	N/A	N/A	N/A
AMRN	AMARIN CORP PLC	$357.46M	$0.87	N/A	N/A	N/A	N/A	-13.86%	N/A	N/A	N/A
VIRI	VIRIOS THERAPEUTICS INC	$6.76M	$0.35	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$197.23M	$6.20	$21.75	250.81%	Strong Buy	4	-2.24%	N/A	N/A	N/A
ALLK	ALLAKOS INC	$127.50M	$1.44	$1.83	27.29%	Hold	3	N/A	N/A	N/A	N/A
ATHA	ATHIRA PHARMA INC	$96.59M	$2.52	$19.00	653.97%	Buy	1	N/A	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$740.34M	$14.21	$18.25	28.43%	Strong Buy	4	N/A	N/A	N/A	N/A
GRI	GRI BIO INC	$1.59M	$0.42	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$58.58M	$5.45	$19.00	248.62%	Strong Buy	4	N/A	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$766.60M	$6.26	$13.17	110.34%	Strong Buy	6	-9.21%	N/A	N/A	N/A
ELEV	ELEVATION ONCOLOGY INC	$197.24M	$3.61	$7.25	100.83%	Strong Buy	4	N/A	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$2.42B	$27.68	$39.63	43.15%	Strong Buy	8	N/A	N/A	N/A	N/A
BLTE	BELITE BIO INC	$1.31B	$44.97	$58.67	30.46%	Strong Buy	3	N/A	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$166.89M	$8.04	$34.40	327.86%	Strong Buy	5	N/A	N/A	N/A	N/A
TNON	TENON MEDICAL INC	$3.18M	$0.85	$3.00	251.29%	Buy	1	N/A	N/A	N/A	N/A
APM	APTORUM GROUP LTD	$24.61M	$4.75	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ALVR	ALLOVIR INC	$89.13M	$0.78	$1.17	50.58%	Hold	3	N/A	N/A	N/A	N/A
SHLT	SHL TELEMEDICINE LTD	$83.60M	$5.10	$11.00	115.69%	Strong Buy	1	8.63%	N/A	N/A	N/A
OPT	OPTHEA LTD	$199.13M	$3.41	N/A	N/A	N/A	N/A	561.69%	N/A	N/A	N/A
LUCD	LUCID DIAGNOSTICS INC	$47.16M	$0.91	$2.75	203.87%	Strong Buy	2	N/A	N/A	N/A	N/A
MBOT	MICROBOT MEDICAL INC	$13.54M	$0.94	$7.00	644.68%	Buy	1	N/A	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$365.89M	$4.66	$15.25	227.25%	Strong Buy	4	N/A	N/A	N/A	N/A
QNRX	QUOIN PHARMACEUTICALS LTD	$3.02M	$0.76	$4.00	426.32%	Strong Buy	1	N/A	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$139.33M	$0.92	$5.00	443.48%	Strong Buy	2	5.81%	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$577.89M	$3.09	$7.14	131.17%	Strong Buy	7	-13.26%	N/A	N/A	N/A
DERM	JOURNEY MEDICAL CORP	$69.04M	$3.45	$8.50	146.38%	Strong Buy	1	-0.78%	N/A	N/A	N/A
AVTE	AEROVATE THERAPEUTICS INC	$592.59M	$20.57	$47.00	128.49%	Strong Buy	3	N/A	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$6.07M	$1.19	$8.00	572.27%	Strong Buy	1	N/A	N/A	N/A	N/A
COSM	COSMOS HEALTH INC	$9.28M	$0.69	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ICUI	ICU MEDICAL INC	$2.53B	$103.99	$123.00	18.28%	Strong Buy	2	0.69%	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$5.45B	$37.31	$64.63	73.21%	Buy	8	9.79%	N/A	N/A	N/A
EBS	EMERGENT BIOSOLUTIONS INC	$290.83M	$5.55	$5.00	-9.91%	Strong Buy	1	-3.86%	N/A	N/A	N/A
INFU	INFUSYSTEM HOLDINGS INC	$137.14M	$6.44	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TSVT	2SEVENTY BIO INC	$246.75M	$4.80	$11.50	139.58%	Strong Buy	4	8.84%	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$1.52B	$37.80	$43.00	13.76%	Strong Buy	5	13.28%	N/A	N/A	N/A
BIOR	BIORA THERAPEUTICS INC	$26.20M	$0.73	$15.00	1,954.79%	Buy	1	118.40%	N/A	N/A	N/A
VNRX	VOLITIONRX LTD	$63.77M	$0.77	$3.50	354.55%	Strong Buy	2	N/A	N/A	N/A	N/A
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$2.85B	$11.32	$11.40	0.71%	Strong Buy	5	4.89%	N/A	N/A	N/A
GRTS	GRITSTONE BIO INC	$85.44M	$0.79	$4.50	471.79%	Buy	2	75.77%	N/A	N/A	N/A
OFIX	ORTHOFIX MEDICAL INC	$562.94M	$15.00	$20.00	33.33%	Strong Buy	1	5.91%	N/A	N/A	N/A
ONCT	ONCTERNAL THERAPEUTICS INC	$25.63M	$8.66	$29.50	240.65%	Strong Buy	2	-19.87%	N/A	N/A	N/A
ALNY	ALNYLAM PHARMACEUTICALS INC	$18.90B	$149.40	$214.00	43.24%	Buy	12	14.84%	N/A	N/A	N/A
POAI	PREDICTIVE ONCOLOGY INC	$6.89M	$1.68	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VVOS	VIVOS THERAPEUTICS INC	$7.39M	$2.29	N/A	N/A	N/A	N/A	134.98%	N/A	-1,386.28%	-68.35%
NRBO	NEUROBO PHARMACEUTICALS INC	$22.86M	$4.66	$10.00	114.59%	Strong Buy	1	N/A	N/A	N/A	N/A
CARM	CARISMA THERAPEUTICS INC	$58.58M	$1.41	$7.00	396.45%	Strong Buy	2	57.09%	N/A	N/A	N/A
XNCR	XENCOR INC	$1.42B	$23.03	$35.67	54.87%	Buy	6	-8.83%	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$20.67M	$0.40	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FLGC	FLORA GROWTH CORP	$16.79M	$1.31	$6.50	396.18%	Strong Buy	2	10.61%	N/A	N/A	N/A
FRES	FRESH2 GROUP LTD	$4.27M	$0.48	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FHTX	FOGHORN THERAPEUTICS INC	$234.65M	$5.51	$16.50	199.46%	Buy	2	14.41%	N/A	N/A	N/A
MDXH	MDXHEALTH SA	$7.86M	$2.88	$7.50	160.42%	Strong Buy	2	11.69%	N/A	N/A	N/A
CYCC	CYCLACEL PHARMACEUTICALS INC	$3.35M	$2.29	$11.00	380.35%	Strong Buy	1	535.19%	N/A	N/A	N/A
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$37.37B	$81.86	$95.33	16.46%	Buy	9	4.04%	N/A	N/A	N/A
SYRA	SYRA HEALTH CORP	$10.21M	$1.59	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BLCO	BAUSCH & LOMB CORP	$5.15B	$14.65	$18.57	26.76%	Buy	7	6.39%	N/A	N/A	N/A
INMB	INMUNE BIO INC	$214.64M	$10.85	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$186.56M	$2.11	$4.50	113.27%	Strong Buy	2	-2.46%	N/A	N/A	N/A
NOTV	INOTIV INC	$50.12M	$1.93	$5.25	172.02%	Hold	3	0.08%	N/A	N/A	N/A
CYTH	CYCLO THERAPEUTICS INC	$40.06M	$1.40	$2.80	100.00%	Buy	2	17.95%	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$6.21M	$0.39	N/A	N/A	N/A	N/A	14.51%	N/A	N/A	N/A
AUNA	AUNA SA	N/A	$8.72	$14.15	62.27%	Strong Buy	4	11.71%	N/A	N/A	N/A
SINT	SINTX TECHNOLOGIES INC	$10.43M	$0.09	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHG	KONINKLIJKE PHILIPS NV	$25.36B	$27.98	N/A	N/A	N/A	N/A	3.97%	N/A	N/A	N/A
VTRS	VIATRIS INC	$13.07B	$10.98	$13.00	18.40%	Hold	1	0.29%	N/A	N/A	N/A
ALIM	ALIMERA SCIENCES INC	$167.64M	$3.20	$8.00	150.00%	Strong Buy	2	N/A	N/A	N/A	N/A
CTSO	CYTOSORBENTS CORP	$52.57M	$0.97	$2.00	106.61%	Buy	2	13.34%	N/A	N/A	N/A
QDEL	QUIDELORTHO CORP	$2.87B	$42.82	$59.00	37.79%	Hold	5	-0.11%	N/A	N/A	N/A
INDV	INDIVIOR PLC	$2.32B	$16.97	$37.00	118.03%	Buy	1	N/A	N/A	N/A	N/A
SENS	SENSEONICS HOLDINGS INC	$257.48M	$0.49	$2.00	312.37%	Buy	1	N/A	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.